Associations of sarcopenia, sarcopenia components and sarcopenic obesity with cancer incidence: A prospective cohort study of 414,094 participants in UK Biobank

  • 0Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

|

|

Summary

This summary is machine-generated.

Sarcopenia, characterized by low muscle strength and mass, is linked to increased cancer risk, particularly liver, blood, and colorectal cancers in males. Early identification of sarcopenia components may aid cancer prevention efforts.

Area Of Science

  • Gerontology
  • Oncology
  • Epidemiology

Background

  • Sarcopenia, a condition defined by reduced muscle strength, mass, and physical performance, is a growing concern in aging populations.
  • Understanding the relationship between sarcopenia and cancer incidence is crucial for public health strategies.

Purpose Of The Study

  • To investigate the association between sarcopenia, its components, and the incidence of various cancers.
  • To explore potential sex differences in these associations.

Main Methods

  • A prospective cohort study utilizing UK Biobank data from 414,094 participants.
  • Sarcopenia and its components were defined using the EWGSOP2 2019 criteria.
  • Cox proportional hazard models were employed, adjusting for multiple confounding factors.

Main Results

  • Sarcopenia was associated with a higher risk of liver, haematological, and colorectal cancers in males.
  • Components of sarcopenia, such as low grip strength and slow walking pace, were linked to increased risks of specific cancers.
  • Sarcopenic obesity was associated with a higher risk of colorectal cancer in males.

Conclusions

  • Sarcopenia, its components, and sarcopenic obesity are associated with an increased risk of several cancers, predominantly in males and affecting the gastrointestinal tract.
  • Early identification of sarcopenia components may contribute to cancer prevention strategies.

Related Concept Videos

Cancer Survival Analysis 01:21

315

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Psychoneuroimmunology: Diabetes and Cancer 01:19

20

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Rous Sarcoma Virus (RSV) and Cancer 01:03

4.9K

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

Obesity 01:24

356

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...